1. Home
  2. TBI vs CDXS Comparison

TBI vs CDXS Comparison

Compare TBI & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$3.31

Market Cap

129.9M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.58

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBI
CDXS
Founded
1985
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
141.8M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
TBI
CDXS
Price
$3.31
$1.58
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
254.5K
3.5M
Earning Date
05-04-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
43.82
EPS
N/A
N/A
Revenue
N/A
$138,590,000.00
Revenue This Year
$6.25
$6.35
Revenue Next Year
$3.90
$16.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$3.42
$0.96
52 Week High
$7.78
$3.87

Technical Indicators

Market Signals
Indicator
TBI
CDXS
Relative Strength Index (RSI) 30.38 56.64
Support Level N/A $1.57
Resistance Level $5.56 $1.86
Average True Range (ATR) 0.23 0.19
MACD -0.00 0.03
Stochastic Oscillator 1.32 42.60

Price Performance

Historical Comparison
TBI
CDXS

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: